The Natural Progression of Parkinson’s Disease in a Small Cohort with 15 Drug-na?ve Patients

被引:0
|
作者
Liu Ying
Fan Jin-Hu
Gao Xiang
Ma Li
Qiao You-Lin
Zhang Lin
机构
[1] USA
[2] Chinese Academy of Medical Sciences and Peking Union Medical College
[3] Dalian Municipal Friendship Hospital
[4] Boston
[5] Cancer Hospital
[6] and Harvard Medical School
[7] China
[8] MA 02115
[9] Brigham and Women’s Hospital
[10] Channing Laboratory
[11] Liaoning 116001
[12] CA 95817
[13] University of California Davis School of Medicine
[14] Department of Nutrition
[15] Harvard University School of Public Health
[16] Department of Neurology
[17] Department of Cancer Epidemiology
[18] Department of Medicine
[19] Sacramento
[20] Beijing 100021
关键词
Drug-na?ve; Epidemiology; Parkinson’s Disease; Progression;
D O I
暂无
中图分类号
R742.5 [震颤麻痹综合征];
学科分类号
摘要
Background: The studies of the natural progression of Parkinson’s disease (PD) in Chinese populations have been lacking. To address this issue and obtain a preliminary data, we conducted a PD progression assessment in 15 adults withde novo PD from a nutritional intervention trial (NIT) cohort in Lin County China.Methods: Using the Copiah County screening questionnaire and United Kingdom Parkinson’s Disease Society Brain Bank diagnostic criteria, we surveyed the available NIT cohort members in 2000 and diagnosed 86 patients as PD. In 2010, we resurveyed all PD patients and confirmed definite PD diagnosis in 15 cases with the rest of them being dead (54); having probable (10) PD or vascular Parkinsonism (3); refusing to participate (2); or being away (2). In both surveys, we used Hoehn and Yahr (HY) scale and assessed the disease progression. Unified Parkinson’s Disease Rating Scale (UPDRS) was added to the second survey.Results: In 2010, the average disease duration for 15 definite PD patients was 13.6 ± 7.3 years. Over a 10-year time span, 9 out of 15 patients remained at the same HY stage while the remaining 6 progressed. Rigidity (47% vs. 100%;P = 0.002) and postural instability (7% vs. 47%;P = 0.005) worsened significantly. The mean UPDRS motor scores in 2010 were 39.4 ± 23.7.Conclusions: Overall worsening of motor function in PD seems to be the rule in this untreated cohort, and their rate of progression seemed to be slower than those reported in the western populations.
引用
收藏
页码:1761 / 1764
页数:4
相关论文
共 50 条
  • [41] Differences in correlations of depression and anhedonia with cardiovascular sympathetic functions during a head-up tilt test in drug-naïve Parkinson’s disease patients
    Hidetomo Murakami
    Tomotaka Shiraishi
    Tadashi Umehara
    Shusaku Omoto
    Maki Takahashi
    Haruhiko Motegi
    Takahiro Maku
    Ryoji Nakada
    Takeo Sato
    Hiroki Takatsu
    Teppei Komatsu
    Keiko Bono
    Kenichiro Sakai
    Hidetaka Mitsumura
    Yasuyuki Iguchi
    Neurological Sciences, 2020, 41 : 2825 - 2830
  • [42] Heart Rate Variability with Deep Breathing in Drug-Naïve Patients with Schizophrenia
    Ying Chun Tai
    Shih-Hsien Lin
    Kao Chin Chen
    I Hui Lee
    Po See Chen
    Lan-Ting Lee
    Hsin Chun Tsai
    Tzung Lieh Yeh
    Yen Kuang Yang
    Applied Psychophysiology and Biofeedback, 2020, 45 : 275 - 282
  • [43] Abnormalities of structural covariance of insular subregions in drug-naïve OCD patients
    Zhang, Xuedi
    Xie, Minyao
    Li, Wangyue
    Xu, Zhihan
    Wang, Zhongqi
    Jiang, Wenjing
    Wu, Yu
    Liu, Na
    CEREBRAL CORTEX, 2024, 34 (01)
  • [44] Long-term treatment with rotigotine in drug-naïve PSP patients
    Tommaso Schirinzi
    Valerio Pisani
    Paola Imbriani
    Giulia Di Lazzaro
    Simona Scalise
    Antonio Pisani
    Acta Neurologica Belgica, 2019, 119 : 113 - 116
  • [45] Disentangling gray matter atrophy and its neurotransmitter architecture in drug-naïve Parkinson's disease: an atlas-based correlation analysis
    Pang, Huize
    Li, Xiaolu
    Yu, Ziyang
    Yu, Hongmei
    Bu, Shuting
    Wang, Juzhou
    Zhao, Mengwan
    Liu, Yu
    Jiang, Yueluan
    Fan, Guoguang
    CEREBRAL CORTEX, 2024, 34 (10)
  • [46] Therapeutic effectiveness of potassium iodine in drug-naïve patients with Graves’ disease: a single-center experience
    Toyoyoshi Uchida
    Hiromasa Goto
    Takatoshi Kasai
    Koji Komiya
    Kageumi Takeno
    Hiroko Abe
    Nayumi Shigihara
    Junko Sato
    Akira Honda
    Tomoya Mita
    Akio Kanazawa
    Yoshio Fujitani
    Hirotaka Watada
    Endocrine, 2014, 47 : 506 - 511
  • [47] Claustral structural connectivity and cognitive impairment in drug naïve Parkinson’s disease
    Alessandro Arrigo
    Alessandro Calamuneri
    Demetrio Milardi
    Enricomaria Mormina
    Michele Gaeta
    Francesco Corallo
    Viviana Lo Buono
    Gaetana Chillemi
    Silvia Marino
    Alberto Cacciola
    Giuseppe Di Lorenzo
    Giuseppina Rizzo
    Giuseppe Pio Anastasi
    Angelo Quartarone
    Brain Imaging and Behavior, 2019, 13 : 933 - 944
  • [48] Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease
    Beatrice Orso
    Francesco Famà
    Laura Giorgetti
    Pietro Mattioli
    Andrea Donniaquio
    Nicola Girtler
    Andrea Brugnolo
    Federico Massa
    Enrico Peira
    Matteo Pardini
    Silvia Morbelli
    Flavio Nobili
    Dario Arnaldi
    Neurological Sciences, 2022, 43 : 2531 - 2536
  • [49] Alterations of structural covariance networks in patients with first-episode drug-na?ve schizophrenia
    李蕾
    China Medical Abstracts(Internal Medicine), 2021, 38 (04) : 233 - 233
  • [50] The common variants implicated in microstructural abnormality of first episode and drug-naïve patients with schizophrenia
    H. Y. Ren
    Q. Wang
    W. Lei
    C. C. Zhang
    Y. F. Li
    X. J. Li
    M. L. Li
    W. Deng
    C. H. Huang
    F. Du
    L. S. Zhao
    Y. C. Wang
    X. H. Ma
    X. Hu
    T. Li
    Scientific Reports, 7